Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-09-023071
Filing Date
2009-04-30
Accepted
2009-04-30 09:52:04
Documents
1
Period of Report
2009-04-19

Document Format Files

Seq Description Document Type Size
1 v146861_ex.html 3  
1 v146861_ex.xml 3 1541
  Complete submission text file 0001144204-09-023071.txt   3430
Mailing Address 2 ELZA STREET JERUSALEM L3 93706
Business Address 2 ELZA STREET JERUSALEM L3 93706 011 972-54-7909058
ORAMED PHARMACEUTICALS INC. (Issuer) CIK: 0001176309 (see all company filings)

EIN.: 980376008 | State of Incorp.: NV | Fiscal Year End: 0831
SIC: 2834 Pharmaceutical Preparations

Mailing Address 20 TARAD RAMAT GAN L3 52503
Business Address
Zommer Yifat Hen (Reporting) CIK: 0001462892 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50298 | Film No.: 09781439